Clinical Trial Update: G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 clinical trial update examining a gemcitabine-based regimen for small cell lung cancer in elderly patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Small Cell Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED